JENNINGS POLICY STRATEGIES for COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER JENNINGS | — |
Pharmacy PHA
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER JENNINGS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.